HomeServicesClient ProfilesPublicationsWorkshopsInformation / ReportsInvestor Referral NetworkConnect With CapitalAbout UsContact Us

Medgraph Incorporated,  www.med-graph.com

Medgraph, located in Rochester, NY, is an innovative telemedicine informatics company.  The company focuses on providing remote patient monitoring technology solutions.

Medgraph is a recipient of Phase I & Phase II Small Business Innovation Research (SBIR) grants from the US Department of Education.  The company is also a 2007 Tibbetts Award Winner, which recognizes an SBIR participant for exemplifying the best in the federal government small business R&D program.

The company hired Eighteen Ventures to provide assistance in preparing business presentation materials, identifying potential private sector investors and connecting Medgraph to potential private sector investors.

Download Now! See How Eighteen Ventures Helped Medgraph Succeed.

 


Zylon Corporation, www.zylon.com

Located West of New York City, Zylon Corporation's core competency involves polymer science as applied to medical devices and clinical procedures.  The company's product development focus includes medical balloon catheters and related devices.

Zylon is a SBIR funding award winner.  The company won funding from the National Institutes of Health (NIH) to research and develop an Ultra Low Profile Coronary Stent Delivery Catheter.

The company hired Eighteen Ventures to provide assistance in preparing business presentation materials, identifying potential private sector investors and connecting Zylon to potential private sector investors.

 


iBiometrics, www.ibiometrics.com

 

Located in Millwood, New York, iBiometrics is a woman-owned, National Science Foundation SBIR Phase I and Phase II awarded firm. The company performs research and development in the areas of voice and data security with expertise in the area of speaker verification.

 

  iBiometrics hired Eighteen Ventures to research and prepare its business plan, which will be used as a working strategy for corporate growth and as a funding presentation to potential capital investors.

 


Enter supporting content here